ID

25202

Beschrijving

Medication form Study ID: 208127/125 Clinical Study ID: 208127/125 (Ext-HAB-038 Month 90) Study Title: A double-blind, randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' combined hepatitis A / hepatitis B vaccine in healthy children between 6 and 15 years of age. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine Trade Name: Twinrix Study Indication: Hepatitis A; Hepatitis B

Trefwoorden

Versies (1)
  1. 28-08-17 28-08-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

28 augustus 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Medication Biologicals HepA/HepB vaccine 208127/125

Engels

Medication Biologicals HepA/HepB vaccine 208127/125

1 Formulieren  
Header
Beschrijving

Header

Alias
UMLS CUI-1
C1320722
Protocol
Beschrijving

Protocol

Datatype

text

Alias
UMLS CUI [1]
C1507394
Subject number
Beschrijving

Subject number

Datatype

text

Alias
UMLS CUI [1]
C2348585
Medication
Beschrijving

Medication

Alias
UMLS CUI-1
C0013227
Trade name
Beschrijving

Trade name

Datatype

text

Alias
UMLS CUI [1]
C2360065
Total Daily Dose
Beschrijving

Total daily dose

Datatype

text

Alias
UMLS CUI [1]
C2348070
Route
Beschrijving

Route

Datatype

text

Alias
UMLS CUI [1]
C0013153
Medical indication
Beschrijving

Where appropriate, medical indication should be recorded using the same terminology in the Adverse Experience Section.

Datatype

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0013227
Code
Beschrijving

Please indicate the corresponding "code" of tbe reported. adverse experience if applicable (eg. "VO", "AE.2"), or code as "P" if used prophylactically in anticipation of vaccine reactions.

Datatype

text

Alias
UMLS CUI [1,1]
C0805701
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0013227
Start Date
Beschrijving

day/month/year

Datatype

date

Alias
UMLS CUI [1]
C0808070
End date, or tick box if continuing at end of study
Beschrijving

day/month/year

Datatype

date

Alias
UMLS CUI [1]
C0806020
tick box if continuing at end of study
Beschrijving

Continuing at end of study

Datatype

boolean

Alias
UMLS CUI [1,1]
C1553904
UMLS CUI [1,2]
C2983670
Terug naar het begin van de pagina

Similar models

Medication Biologicals HepA/HepB vaccine 208127/125

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Header
C1320722 (UMLS CUI-1)
Protocol
Item
Protocol
text
C1507394 (UMLS CUI [1])
Subject number
Item
Subject number
text
C2348585 (UMLS CUI [1])
Item Group
Medication
C0013227 (UMLS CUI-1)
Trade name
Item
Trade name
text
C2360065 (UMLS CUI [1])
Total daily dose
Item
Total Daily Dose
text
C2348070 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Medical indication
Item
Medical indication
text
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Code for medical indication
Item
Code
text
C0805701 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Start date
Item
Start Date
date
C0808070 (UMLS CUI [1])
End date
Item
End date, or tick box if continuing at end of study
date
C0806020 (UMLS CUI [1])
Continuing at end of study
Item
tick box if continuing at end of study
boolean
C1553904 (UMLS CUI [1,1])
C2983670 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial